Skip to main content

Table 3 Standard and modified thromboelastography in all studied patients (pooled data)

From: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study

 

TP1

TP2

TP3

p

Reaction time (mm)

16.7 (13.3–21.6)

17.5 (13.8–21.1)

17.4 (12.9–21.3)

0.84

Coagulation time (mm)

12 (7.3–25.1)

13.7 (7.5–33.2)

15.0 (5.85–33.0)

0.07

Maximal amplitude (mm)

38.5 (26.8–48.8)

35.5 (25.1–50.2)

34.0 (22.7–48.2)

0.0003

Angle alpha (degree)

35 (24.5–51.1)

42 (23.7–54.8)

30.0 (17.8–53.5)

0.002

Clot lysis (percent)

100 (98.7–100)

100 (99.1–100)

100 (98.4–100)

0.68

Coagulation index

-0.68 (-6.3–3.9)

-1.0 (-6.3–3.6)

-1.5 (-7.7–4.6)

0.81

RHEP(mm)

0.7 (-0.5–2.6)

2.9 (0.125–5)

1.4 (0.2–4.1)

0.07

MAPLT (mm)

24 (12.5–31.1)

20 (13.6–28.6)

19 (8.1–29.5)

0.3

  1. MAPLT, difference between standard and abximimab-fab-modified maximal amplitude (MA) reflecting solely the platelet function. RHEP, difference between standard and heparinase modified reaction time (R), reflecting the effects of endogenous/exogenous heparinoids on plasmatic coagulation. TP, time point.